Dr. Ken Massey is responsible for driving market leadership for Saama’s award-winning life sciences data analytics solutions. Prior to joining Saama, he had a 25-year career in the pharmaceutical industry, successfully leading and growing teams in clinical operations and global medical affairs. As Vice President, US Medical Affairs at Merck & Co., Ken led overall strategic planning, governance, and management of a multi-disciplinary organization consisting of field medical professionals, professional society/patient advocacy groups, continuing medical education providers, key scientific leaders and market decision makers. Before joining Merck, he was Head, Medical Affairs at Mitsubishi Tanabe Pharma America. Ken began his pharmaceutical career at Marion Laboratories, where he provided scientific recommendations for new product acquisitions before assuming key Medical Affairs and Drug Development leadership positions at Novartis, Parke-Davis, and Bristol-Meyers Squibb. Ken received his B.S. and Pharm.D. degrees from the University of Florida in Gainesville. He completed a two-year post-doctoral fellowship in pediatric clinical pharmacology under the direction of Allan Neims, M.D., and Leslie Hendeles, Pharm.D., prior to joining the faculty at the University of Tennessee.